• Ebtehaj S Almughais, Ali H Alharbi, Hadi A Aldarwish, Areeb F Alshammari, Razan S Alsuhaymi, Jumanah A Almuaili, and Atheer M Alanizy.
• From the Department of Family & Community Medicine (Almughais), College of Medicine and from the College of Medicine (Alharbi, Aldarwish, Alshammari, Alsuhaymi, Almuaili, Alanizy), University of Hail, Hail, Kingdom of Saudi Arabia.
• Saudi Med J. 2022 Apr 1; 43 (4): 386393386-393.

ObjectivesTo measure and assess the side-effects of Pfizer/BioNTech and AstraZeneca vaccines on residents of Saudi Arabia, as well as provide a database that gives insight into the relative safety of these 2 COVID-19 vaccines.MethodsA community-based cross-sectional study was conducted to determine the side-effects of the two COVID-19 vaccines. The study was initiated on the 5th of June 2021 at Hail University, Hail, Saudi Arabia. The information was collected through an online survey designed on Google forms. The questionnaire was pre-tested for validity, with all information carefully reviewed.ResultsThe study included 2,530 participants from different regions of Saudi Arabia, with a mean age of 26.9 ± 12.4 years old. The most common vaccine among the study group was Pfizer, which 73.8% of the population were provided; the remaining 26.2% received the AstraZeneca vaccine. Regarding the Pfizer vaccine, the common systemic side-effects followed the first dose, included headaches, followed by muscle pain, fever, and joint pain. Those who had the AstraZeneca vaccine reported a few more side-effects. For example, during the first dose fever was reported as the most common side-effect, followed by headache, muscle pain and fatigue.ConclusionThe present study confirmed that vaccine side-effects are more frequently reported by smokers and those who received the AstraZeneca vaccine. Further studies are needed to acquire a better understanding of the association between risk factors and the experiencing of post-vaccine side-effects.Copyright: © Saudi Medical Journal.

23 keywords...

hide…